A significant decrease in the activity of MMP-2 was observed after 24 h exposure to As2O3 and berberine (Figure 7B), likely explaining why co-treatment with berberine and As2O3 strongly affects glioma cell migration and invasiveness. The gene discussed is MMP2; the disease is central nervous system cancer.